3 news items
Notable Labs Reports 2023 Financial Results and Provides a Business Update
NTBL
12 Apr 24
to tax laws or rates, pharmaceutical regulations, and other regulations. Actual results and the timing of events could differ materially from those
Notable Labs Presents the Design Plan for the PPMP-Enabled Phase 2 Trial with Volasertib for Relapsed/Refractory AML at AACR 2024
NTBL
9 Apr 24
) changes in, or additions to international, federal, state or local legislative requirements, such as changes in or additions to tax laws or rates
Notable Labs Presentation of Data Related to Innovations in the Use of Cryopreserved Samples in the PPMP Assay at AACR 2024 Expands the Potential of the Platform
NTBL
8 Apr 24
to international, federal, state or local legislative requirements, such as changes in or additions to tax laws or rates, pharmaceutical regulations, and other
- Prev
- 1
- Next